Provided by Tiger Trade Technology Pte. Ltd.

Amgen

413.61
-7.9000-1.87%
Volume:483.38K
Turnover:201.49M
Market Cap:222.72B
PE:25.69
High:422.80
Open:421.72
Low:413.06
Close:421.51
52wk High:447.03
52wk Low:283.00
Shares:538.48M
Float Shares:536.99M
Volume Ratio:0.55
T/O Rate:0.09%
Dividend:9.80
Dividend Rate:2.37%
EPS(TTM):16.10
EPS(LYR):14.23
ROE:91.47%
ROA:8.67%
PB:19.06
PE(LYR):29.07

Loading ...

Amgen Says Repatha Cuts Death Risk 20% in High-Risk Patients

MT Newswires Live
·
Aug 31

Amgen Repatha reduces risk of death in high-risk adults for first heart attack

TIPRANKS
·
Aug 31

Amgen's Repatha® Reduces Risk of Death in Patients at High Risk for a First Heart Attack or Stroke

THOMSON REUTERS
·
Aug 31

Amgen Inc. Stock Underperforms Friday When Compared to Competitors

Dow Jones
·
Aug 29

Amgen’s Pediatric Psoriasis Study Wrap-Up: What Apremilast Safety Data Means for Investors

TIPRANKS
·
Aug 29

Political and General News Events from August 28

Reuters
·
Aug 28

Amgen’s AMG 691 Phase 1 Trial Targets Key Growth in Asian Markets

TIPRANKS
·
Aug 28

Analysts Offer Insights on Healthcare Companies: Verrica Pharmaceuticals (VRCA) and Amgen (AMGN)

TIPRANKS
·
Aug 27

HBM Holdings FY26 H1 Profit Falls 11.16% to US$ 64.85 Million; Revenue Rises 20.9% to US$ 122.49 Million

Reuters
·
Aug 27

Amgen, AstraZeneca announce Crossing trial showed ‘meaningful’ improvements

TIPRANKS
·
Aug 27

Amgen, AstraZeneca report CROSSING trial met co-primary and secondary endpoints

TIPRANKS
·
Aug 27

AstraZeneca, Amgen Phase 3 Trial Shows Tezspire Eases Swallowing Difficulties for EoE Patients

MT Newswires Live
·
Aug 27

AstraZeneca-Amgen Asthma Drug Succeeds in Late-Stage Oesophagus Disease Trial

Reuters
·
Aug 27

Amgen - Tezspire Safety Profile Consistent with Approved Indications

THOMSON REUTERS
·
Aug 27

Tezspire® Demonstrates Positive Phase 3 Results in Eosinophilic Esophagitis Across Both Co-Primary and All Key Secondary Endpoints

THOMSON REUTERS
·
Aug 27

Sino Biopharmaceutical Stock Climbs 2.1% in Hong Kong, Outperforms Competitors

Dow Jones
·
Aug 26

Political and General News Events from August 25

Reuters
·
Aug 25

Amgen Inc. Stock Underperforms Monday When Compared to Competitors Despite Daily Gains

Dow Jones
·
Aug 25

Amgen Extends MariTide Study In Obesity And Diabetes, Keeping Investor Focus On Long-Term Potential

TIPRANKS
·
Aug 25

Political and General News Events from August 24

Reuters
·
Aug 24